Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.83 -0.12 (-0.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Aurinia Pharmaceuticals (AUPH) reported Return on Capital Employed [ROCE] of 22.90% for Q2 2026, up 10.68 percentage points from 12.22% a year earlier and up 3.79 percentage points from the prior quarter.

Analysis

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Aurinia Pharmaceuticals posted Return on Capital Employed [ROCE] of 18.82%, up 19.86 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased for four consecutive years, with a five-year change of +47.63 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -1.04% in FY2024 (+20.17 pp), -21.21% in FY2023 (+2.97 pp), -24.18% in FY2022 (+14.87 pp) and -39.05% in FY2021 (-10.24 pp).
  • The Q2 2026 figure ranks as the highest quarterly Return on Capital Employed [ROCE] in data going back to Q1 2021.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last 17 quarters, with an average year-over-year change of +18.18 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q2 2025 (a gain of 25.92 percentage points); the low point was Q1 2022 (a drop of 3.73 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 19.12% (Q1 2026), 19.22% (Q4 2025) and 15.95% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Aurinia Pharmaceuticals 2.10 Bn 532.21 Mn 76.67 Mn 22.90%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.90%
Mar 31, 2026 19.12%
Dec 31, 2025 19.22%
Sep 30, 2025 15.95%
Jun 30, 2025 12.22%
Mar 31, 2025 6.62%
Dec 31, 2024 -1.04%
Sep 30, 2024 -7.14%
Jun 30, 2024 -13.70%
Mar 31, 2024 -16.34%
Dec 31, 2023 -19.33%
Sep 30, 2023 -18.85%
Jun 30, 2023 -19.00%
Mar 31, 2023 -24.61%
Dec 31, 2022 -25.72%
Sep 30, 2022 -26.18%
Jun 30, 2022 -34.12%
Mar 31, 2022 -34.21%
Dec 31, 2021 -43.97%
Sep 30, 2021 -46.50%
API Access

Aurinia Pharmaceuticals Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AUPH&period=max&api_key=YOUR_API_KEY